date,text,url,title,source_domain,authors,description,language
2025-03-25,"Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via Email

Apple's dwindling China business: Here's what you need to know

CNBC’s Steve Kovach joins ‘Halftime Report’ to discuss the latest news on Apple's China business as Tim Cook visits the China Development Forum.",https://www.cnbc.com/video/2025/03/25/apples-dwindling-china-business-heres-what-you-need-to-know.html,Apple's dwindling China business: Here's what you need to know,http://www.cnbc.com,,,
2025-03-25,"BENSALEM, Pa., March 25, 2025 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.
Investors suffering losses on their investments are encouraged to contact the Law Offices of Howard G. Smith to discuss their legal rights in these class actions at (215) 638-4847 or by email to howardsmith@howardsmithlaw.com.
Alarum Technologies Ltd. (NASDAQ: ALAR)
Class Period: March 14, 2024 – August 26, 2024
Lead Plaintiff Deadline: April 15, 2025
The complaint alleges that throughout the Class Period the defendants made false and/or misleading statements and/or failed to disclose that: (1) the Company was less effective in retaining and/or expanding customer engagements than it had represented to investors; (2) the foregoing would impair Alarum’s ability to generate consistent revenue growth; (3) accordingly, Alarum’s business and/or financial prospects were overstated; and (4) as a result, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times.
Venture Global, Inc. (NYSE: VG)
Class Period: January 2025 IPO
Lead Plaintiff Deadline: April 18, 2025
The complaint alleges that throughout the Class Period the defendants made false and/or misleading statements and/or failed to disclose that: (1) Venture did not have the customer backing to implement its projects, allowing for the Company to deliver LNG to the world; and (2) as a result, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times.
Constellation Brands, Inc. (NYSE: STZ)
Class Period: April 11, 2024 – January 8, 2025
Lead Plaintiff Deadline: April 21, 2025
The complaint alleges that throughout the Class Period the defendants made false and/or misleading statements and/or failed to disclose that: (1) the Company had failed to improve mix, inventory and sales execution and investments made in media spend and price promotions as well as adjustments in sales capabilities to support distributor partners had not been as effective as they claimed; and (2) as a result, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times.
The Trade Desk, Inc. (NASDAQ: TTD)
Class Period: May 9, 2024 – February 12, 2025
Lead Plaintiff Deadline: April 21, 2025
The complaint alleges that throughout the Class Period the defendants made false and/or misleading statements and/or failed to disclose that: (1) Trade Desk was experiencing significant, ongoing, self-inflicted execution challenges rolling out Kokai, including transitioning clients to Kokai from the Company’s older platform Solimar; (2) such execution challenges meaningfully delayed the Kokai Rollout; (3) Trade Desk’s inability to effectively execute the Kokai Rollout negatively impacted the Company’s business and operations, particularly revenue growth; and (4) as a result, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times.
To be a member of these class actions, you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action. If you wish to learn more about these class actions, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020, by telephone at (215) 638-4847 or by email to howardsmith@howardsmithlaw.com, or visit our website at www.howardsmithlaw.com.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
Contacts
Law Offices of Howard G. Smith
Howard G. Smith, Esquire
215-638-4847
888-638-4847
howardsmith@howardsmithlaw.com
www.howardsmithlaw.com",https://www.globenewswire.com/news-release/2025/03/25/3049000/3448/en/DEADLINE-ALERT-for-ALAR-VG-STZ-TTD-Law-Offices-of-Howard-G-Smith-Reminds-Investors-of-Opportunity-to-Lead-Securities-Fraud-Class-Actions.html,"DEADLINE ALERT for ALAR, VG, STZ, TTD: Law Offices of",www.globenewswire.com,Law Offices Of Howard G. Smith,"BENSALEM, Pa., March 25, 2025 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf...",en
2025-03-25,"Dublin, March 25, 2025 (GLOBE NEWSWIRE) -- The ""Lisinopril (CAS 76547-98-3) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029"" report has been added to ResearchAndMarkets.com's offering.
This report on Lisinopril provides comprehensive insights, including general information, synonyms, chemical composition, safety, hazards, handling, storage, and toxicological and ecological details, along with transport information. This in-depth study serves as a vital resource for understanding the Lisinopril market landscape and its growth potential worldwide.
It explores various applications and examines manufacturing methods, supported by an analysis of relevant patents. The global market analysis covers constraints, drivers, and opportunities from 2019 to 2024, supply and demand dynamics, suppliers and regional overviews across Europe, Asia, North America, and other regions.
The report forecasts future trends and supply-demand scenarios up to 2029, with detailed market predictions by region. Additionally, it analyzes market prices across different regions and evaluates the end-use sectors for Lisinopril.
The Lisinopril global market report covers the following key points:
Lisinopril description, applications and related patterns
Lisinopril market drivers and challenges
Lisinopril manufacturers and distributors
Lisinopril prices
Lisinopril end-users
Lisinopril downstream industries trends
Key questions answered in the report:
What were the main trends of the global Lisinopril market in 2019-2024?
What was the size of the global Lisinopril market in 2019-2024?
Who are the main players in the global Lisinopril market?
Which drivers and challenges will determine the development of the global Lisinopril market during 2025-2029?
What will the CAGRs be for the global product industry?
Key Topics Covered:
1. LISINOPRIL
1.1. General information, synonyms
1.2. Composition, chemical structure
1.3. Safety information
1.4. Hazards identification
1.5. Handling and storage
1.6. Toxicological & ecological information
1.7. Transport information
2. LISINOPRIL APPLICATIONS
3. LISINOPRIL MANUFACTURING METHODS
4. LISINOPRIL PATENTS
5. LISINOPRIL WORLD MARKET ANALYSIS
5.1. Lisinopril market constraints, drivers and opportunities in 2019-2024
5.2. Lisinopril supply/demand in 2019-2024
5.3. Lisinopril market overview by region - Europe, Asia, North America, etc.
6. MANUFACTURERS OF LISINOPRIL
6.1. Lisinopril manufacturers in Europe
6.2. Lisinopril manufacturers in Asia
6.3. Lisinopril manufacturers in North America
6.4. Lisinopril manufacturers in RoW
7. SUPPLIERS OF LISINOPRIL
7.1. Lisinopril suppliers in Europe
7.2. Lisinopril suppliers in Asia
7.3. Lisinopril suppliers in North America
7.4. Lisinopril suppliers in RoW
8. LISINOPRIL WORLD MARKET FORECAST
8.1. Future trends in global Lisinopril market
8.2. Lisinopril supply/demand forecast to 2029
8.3. Lisinopril market forecast to 2029 by region (Europe, Asia, North America, etc.)
9. LISINOPRIL MARKET PRICES
9.1. Lisinopril prices in Europe
9.2. Lisinopril prices in Asia
9.3. Lisinopril prices in North America
9.4. Lisinopril prices in RoW
10. LISINOPRIL END-USE SECTOR
For more information about this report visit https://www.researchandmarkets.com/r/e0ej75
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.",https://www.globenewswire.com/news-release/2025/03/25/3048993/28124/en/Lisinopril-CAS-76547-98-3-Industry-Report-2025-Global-and-Regional-Market-Trends-2019-2024-and-Forecasts-2025-2029-Manufacturers-Market-Prices-Patents-Down-stream-Industries.html,Lisinopril (CAS 76547-98-3) Industry Report 2025: Global,www.globenewswire.com,Research,"Dublin, March 25, 2025 (GLOBE NEWSWIRE) -- The",en
